Home
About Us
Support Staff
Science Board
In Remembrance
Walter Leaman
Gary Lorenzen
R. Gerald Markle
Supporters of Our Efforts Against Pancreatic Cancer
Why the name Pancreatica?
Expanded Mission Statement
Advocacy
How To Use This Site
Privacy Policy
Advertising & Financial Policy
Your Help & Input
Donations
Medical Literature
Events
FAQ's
What is pancreatic cancer?
What are the stages of pancreatic cancer?
How is pancreatic cancer diagnosed?
What is the surgical treatment of pancreatic cancer?
What is the medical treatment of pancreatic cancer?
What are emerging therapies in regard to the treatment of pancreatic cancer?
What are alternative or complementary treatments of pancreatic cancer?
What about neuroendocrine (islet cell tumors)?
What about clinical trials?
How do I find the best doctor for me?
How do I locate the best institution for me?
What are some of the main troubling symptoms and their treatment?
Where can I find support?
How do I approach certain financial and legal matters?
Where can I find more information on hospice and end of life issues?
About Pancreatic Cancer
Clinical Trials
Research Resources
Select Abstracts
Select Links
Stories of Inspiration
Mary DiPaolo
Dale Haskell
Judith Hettler
Shari Marchand
Ted McFerrin
Joseph E. O'Neill
Richard Philbin
Brian Pochel
Milo's Corner Survivor Research
Pancreatic Cancer Registries
Neuroendocrine Pancreatic Cancer Tumors
Neuroendocrine Overview
Neuroendocrine Clinical Trials For Neuroendocrine Tumors
Neuroendocrine Medical Literature
Neuroendocrine Select Abstracts
Neuroendocrine Tumor Links
Pancreatic Cancer Latest News
Links
Mini Links
Annotated Links
Full Links
Contact Us
View by Year:
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
Medical Literature
Serum-Based Protein Immunoassay Can Detect Early Pancreatic Cancer
Monday, April 2, 2012
Abstract
>>
Outcome after laparoscopic enucleation for non-functional neuroendocrine pancreatic tumours.
Thursday, March 1, 2012
Abstract
>>
Potential contribution of preoperative neoadjuvant concurrent chemoradiation therapy on margin-negative resection in borderline resectable pancreatic cancer.
Thursday, March 1, 2012
Abstract
>>
Clinical Calculator of Conditional Survival Estimates for Resected and Unresected Survivors of Pancreatic Cancer.
Monday, February 20, 2012
Abstract
>>
02/20/2012
Fate of the Pancreatic Remnant After Resection for an Intraductal Papillary Mucinous Neoplasm: A Longitudinal Level II Cohort Study.
(
Abstract
)
02/20/2012
The Associations of Advanced Glycation End Products and Its Soluble Receptor with Pancreatic Cancer Risk: A Case-Control Study within the Prospective EPIC Cohort.
(
Abstract
)
02/17/2012
Analysis of lymph node metastasis in pancreatic neuroendocrine tumors (PNETs) based on the tumor size and hormonal production.
(
Abstract
)
02/15/2012
Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer.
(
Abstract
)
02/15/2012
MicroRNA Alterations of Pancreatic Intraepithelial Neoplasias.
(
Abstract
)
02/14/2012
Gemcitabine Alone versus combination of Gemcitabine and Cisplatin for the Treatment of Patients with Locally Advanced and/or Metastatic Pancreatic Carcinoma:
(
Abstract
)
02/14/2012
Incidental Detection of Pancreatic Neuroendocrine Tumors: An Analysis of Incidence and Outcomes.
(
Abstract
)
02/14/2012
Phase 1 study of rigosertib, an inhibitor of the phosphatidylinositol 3-kinase and polo-like kinase 1 pathways, combined with gemcitabine in patients with solid tumors and pancreatic cancer.
(
Abstract
)
02/13/2012
Long-term results of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic carcinoma.
(
Abstract
)
02/07/2012
Early Mortality Risk Score: Identification of Poor Outcomes Following Upfront Surgery for Resectable Pancreatic Cancer.
(
Abstract
)
02/06/2012
Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?
(
Abstract
)
02/03/2012
Urine metabolic signature of pancreatic ductal adenocarcinoma by (1)h nuclear magnetic resonance: identification, mapping, and evolution.
(
Abstract
)
02/02/2012
A Phase II Trial of nab-Paclitaxel as Second-line Therapy in Patients With Advanced Pancreatic Cancer.
(
Abstract
)
02/02/2012
An Epigenetic Approach to Pancreatic Cancer Treatment: the Prospective Role of Histone Deacetylase Inhibitors.
(
Abstract
)
02/01/2012
Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303).
(
Abstract
)
02/01/2012
Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas.
(
Abstract
)
02/01/2012
Incidentally discovered solid pancreatic masses: imaging and clinical observations.
(
Abstract
)
02/01/2012
Outcomes of primary surveillance for intraductal papillary mucinous neoplasm
(
Abstract
)
02/01/2012
Pancreatic adenocarcinoma: complete tumor extirpation improves survival benefit despite larger tumors for patients who undergo distal pancreatectomy and splenectomy.
(
Abstract
)
02/01/2012
Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors.
(
Abstract
)
01/31/2012
Tumor Invasion of Muscular Vessels Predicts Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma Who Have Received Neoadjuvant Therapy and Pancreaticoduodenectomy.
(
Abstract
)
01/26/2012
High-dose Helical Tomotherapy with Concurrent Full-dose Chemotherapy for Locally Advanced Pancreatic Cancer.
(
Abstract
)
01/26/2012
Laparoscopic resection of exocrine carcinoma in central and distal pancreas results in a high rate of radical resections and long postoperative survival.
(
Abstract
)
01/21/2012
Resected Pancreatic Neuroendocrine Tumors: Patterns of Failure and Disease-Related Outcomes With or Without Radiotherapy.
(
Abstract
)
01/19/2012
Defined Clinical Classifications Are Associated with Outcome of Patients with Anatomically Resectable Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy.
(
Abstract
)
01/17/2012
Phase I evaluation of intravenous ascorbic Acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.
(
Abstract
)
01/17/2012
Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study).
(
Abstract
)
01/15/2012
MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma.
(
Abstract
)
01/12/2012
Adjuvant PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) or Gemcitabine Followed by Chemoradiation in Pancreatic Cancer: A Randomized Phase II Trial.
(
Abstract
)
01/12/2012
Frequent Detection of Pancreatic Lesions in Asymptomatic High-Risk Individuals.
(
Abstract
)
01/04/2012
Safety and efficacy of everolimus in adult patients with neuroendocrine tumors.
(
Abstract
)
01/03/2012
The GOFURTGO Study: AGITG phase II study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer.
(
Abstract
)
01/01/2012
A modified pancreaticojejunostomy: kissing pancreaticojejunostomy
(
Abstract
)
01/01/2012
Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer.
(
Abstract
)
01/01/2012
Factors influencing outcome in patients undergoing portal vein resection for adenocarcinoma of the pancreas.
(
Abstract
)
01/01/2012
The potential for induction peptide receptor chemoradionuclide therapy to render inoperable pancreatic and duodenal neuroendocrine tumours resectable.
(
Abstract
)
RSS Feed
Home
> Medical Literature
Sign up for our Free Monthly Newsletter.
RSS Feed